Value of combined CT parameters in distinguishing benign from malignant adrenal masses in cancer patients

被引:3
|
作者
Mohamed, Ahmed Mostafa [1 ]
Moftah, Sherine George [1 ]
El-Lithy, Mahmoud Abbas [2 ]
机构
[1] Ain Shams Univ, Fac Med, Dept Diagnost Radiol, Cairo, Egypt
[2] Ain Shams Univ, Fac Med, Dept Radiat Oncol, Cairo, Egypt
来源
关键词
CT; Adrenal mass; Attenuation; Histogram;
D O I
10.1016/j.ejrnm.2012.01.006
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The aim of this work was to evaluate the effectiveness of combined CT parameters in distinguishing benign from malignant adrenal masses in cancer patients. The study included 33 patients with 39 adrenal masses. CT protocol included pre-contrast scan, dynamic and delayed contrast-enhanced scans assessing the mass size, pre-contrast attenuation, histogram & post-contrast absolute percentage washout (APW). Sensitivities, specificities, accuracies & P-values were calculated for individual and combined parameters. Adrenal masses included 13 lipid rich, nine lipid poor adenomas, one carcinoma and 16 metastases. Size was accurate in the differentiation of 26 of the total 39 masses (66.7%). Accuracy (82.05%) & specificity (68.18%) for the 10% negative pixels threshold on histogram were higher as compared to 76.9% & 59% for the 10 HU mean attenuation threshold. Using APW of 55% at 10 min delay, a sensitivity of 88.23%, a specificity of 86.36% & an accuracy of 87.17% were calculated. The combination of pre-contrast attenuation & histogram values and the APW were highly significant for the differentiation of benign & malignant adrenal masses (P-value is < 0.001). Combining the CT parameters including the pre-contrast attenuation values, histogram & the post-contrast washout analysis yielded a powerful diagnostic protocol with 74.3% accuracy, excluding the size parameter. (C) 2012 Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier B.V.
引用
收藏
页码:275 / 283
页数:9
相关论文
共 50 条
  • [31] Diagnostic accuracy of inflammatory markers for distinguishing malignant and benign ovarian masses
    Eo, Wan Kyu
    Kim, Ki Hyung
    Park, Eun Joo
    Kim, Heung Yeol
    Kim, Hong-bae
    Koh, Suk Bong
    Namkung, Jeong
    JOURNAL OF CANCER, 2018, 9 (07): : 1165 - 1172
  • [32] Validation of a marker panel for distinguishing between benign and malignant pelvic masses
    Hogdall, E.
    Engelholm, S. A.
    Nedergaard, L.
    Petri, A. L.
    Risum, S.
    Pedersen, A. T.
    Hartwell, D.
    Lundvall, L.
    Hogdall, C.
    Zhang, Z.
    Lomas, L.
    Yip, C.
    Meng, X.
    Fung, E. T.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S60 - S60
  • [33] The application value of CDFI and SMI combined with serological markers in distinguishing benign and malignant thyroid nodules
    Li, Fang
    Sun, Wei
    Liu, Lihua
    Meng, Zhen
    Su, Jianli
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24 (11): : 2200 - 2209
  • [34] The application value of CDFI and SMI combined with serological markers in distinguishing benign and malignant thyroid nodules
    Fang Li
    Wei Sun
    Lihua Liu
    Zhen Meng
    Jianli Su
    Clinical and Translational Oncology, 2022, 24 : 2200 - 2209
  • [35] DIFFERENTIATION OF MALIGNANT FROM BENIGN ADRENAL MASSES - PREDICTIVE INDEXES ON COMPUTED-TOMOGRAPHY
    HUSSAIN, S
    BELLDEGRUN, A
    SELTZER, SE
    RICHIE, JP
    GITTES, RF
    ABRAMS, HL
    AMERICAN JOURNAL OF ROENTGENOLOGY, 1985, 144 (01) : 61 - 65
  • [36] EUS-derived criteria for distinguishing benign from malignant metastatic solid hepatic masses
    Fujii-Lau, Larissa L.
    Abu Dayyeh, Barham K.
    Bruno, Marco J.
    Chang, Kenneth J.
    DeWitt, John M.
    Fockens, Paul
    Forcione, David
    Napoleon, Bertrand
    Palazzo, Laurent
    Topazian, Mark D.
    Wiersema, Maurits J.
    Chak, Amitabh
    Clain, Jonathan E.
    Faigel, Douglas O.
    Gleeson, Ferga C.
    Hawes, Robert
    Iyer, Prasad G.
    Rajan, Elizabeth
    Stevens, Tyler
    Wallace, Michael B.
    Wang, Kenneth K.
    Levy, Michael J.
    GASTROINTESTINAL ENDOSCOPY, 2015, 81 (05) : 1188 - U491
  • [37] Distinguishing Benign from Malignant Masses at Breast US: Combined US Elastography and Color Doppler US-Influence on Radiologist Accuracy
    Cho, Nariya
    Jang, Mijung
    Lyou, Chae Yeon
    Park, Jeong Seon
    Choi, Hye Young
    Moon, Woo Kyung
    RADIOLOGY, 2012, 262 (01) : 80 - 90
  • [38] THE VALUE OF CT IN DIFFERENTIATION OF ADRENAL ADENOMAS FROM MALIGNANT TUMORS
    王东
    熊明辉
    张挽时
    徐家兴
    喻敏
    Chinese Journal of Cancer Research, 2001, (01) : 77 - 81
  • [39] ROC curve analysis of PET-FDG for distinguishing between benign and malignant breast masses cancer
    Adler, LP
    Schnur, KC
    Faulhaber, PF
    Shenk, RR
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (05) : 384 - 384
  • [40] Value of inversion imaging to diagnosis in differentiating malignant from benign breast masses
    Li, Na
    Hou, Zhongguang
    Wang, Jiajia
    Bi, Yu
    Wu, Xiabi
    Zhan, Yunyun
    Peng, Mei
    BMC MEDICAL IMAGING, 2023, 23 (01)